GDF15 and familial dilated cardiomyopathy: Multiple studies have proven that GDF-15 synthesis is higher in a prediabetic state and in diabetic patients as opposed to individuals without this conditions, placing GDF-15 as a promising biomarker for uncovering DCM and its implications in diabetic patients [48,49].